| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88165746 | FILING DATE | 10/23/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | BUSH, KAREN K |
L.O. ASSIGNED | 108 |
PUB INFORMATION |
|||
| RUN DATE | 12/19/2020 | ||
| PUB DATE | 02/26/2019 | ||
| STATUS | 732-THIRD EXTENSION - GRANTED | ||
| STATUS DATE | 12/18/2020 | ||
| LITERAL MARK ELEMENT | THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Vivera Pharmaceuticals, Inc. |
| ADDRESS | 4533 MacArthur Blvd., #5049 Newport Beach, CA 92660 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Nevada |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical and pharmaceutical consultation; Pharmaceutical advice; Dispensing of pharmaceuticals; Medical services, namely, non-addictive treatment of chronic pain; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/19/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 037 |
| 12/18/2020 | EX3G | S | EXTENSION 3 GRANTED | 036 |
| 10/23/2020 | EXT3 | S | EXTENSION 3 FILED | 035 |
| 12/11/2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | 034 |
| 12/11/2020 | TPEX | I | EXTENSION RECEIVED WITH TEAS PETITION | 033 |
| 12/11/2020 | PETG | O | PETITION TO REVIVE-GRANTED | 032 |
| 12/11/2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | 031 |
| 11/23/2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 030 |
| 11/23/2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | 029 |
| 10/08/2020 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | 028 |
| 10/08/2020 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | 027 |
| 10/06/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 026 |
| 10/05/2020 | EX2G | S | EXTENSION 2 GRANTED | 025 |
| 04/23/2020 | EXT2 | S | EXTENSION 2 FILED | 024 |
| 10/05/2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 023 |
| 08/11/2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | 022 |
| 08/10/2020 | TPEX | I | EXTENSION RECEIVED WITH TEAS PETITION | 021 |
| 08/10/2020 | PETG | O | PETITION TO REVIVE-GRANTED | 020 |
| 08/10/2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | 019 |
| 06/08/2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 018 |
| 06/08/2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | 017 |
| 11/13/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 016 |
| 11/13/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 015 |
| 10/18/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 014 |
| 10/16/2019 | EX1G | S | EXTENSION 1 GRANTED | 013 |
| 10/16/2019 | EXT1 | S | EXTENSION 1 FILED | 012 |
| 10/16/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 011 |
| 04/22/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 010 |
| 04/22/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 009 |
| 04/23/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 008 |
| 02/26/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 007 |
| 02/26/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 006 |
| 02/06/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 005 |
| 01/17/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 004 |
| 01/15/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 11/04/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 10/26/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Bruce Hare |
| CORRESPONDENCE ADDRESS | Bruce Hare Genius Patent APC 2305 Historic Decatur Road Suite 100 San Diego CA 92106 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Vivera Pharmaceuticals, Inc. |
| ADDRESS | 4533 MacArthur Blvd., #5049 Newport Beach, CA 92660 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Nevada |